1 Comment
⭠ Return to thread

Hi Steve,

I had been reading and sharing your articles as a free subscriber. Recently I shared this one with a group of friends. His reply has prompted me to subscribe specifically so I could get your feedback on his reply after he read your article. Here it is:

He refers to the Danish cohort study by Hansen et al. that I've been using

to argue against the booster. "Durable" against omicron? Hardly. The

thing is, somebody will undoubtedly find some other preprint that shows a

different result, and the authorities will choose to follow it instead.

When there is a contradiction in results, I prefer to look at real world

data: Gibraltar is effectively 100 percent vaccinated, and they just had

their worst surge of the entire pandemic because of omicron; South Korea

is 80 percent vaccinated, and they are having their worst surge of the

entire pandemic because of omicron; Cornell University had over 900 students

infected in less than a week (about 4 percent of the student body) forcing

the school to move fall semester finals entirely on-line, despite the

student body being 99 percent vaccinated due to the mandate; the University

of Hawaii student body is 97 percent vaccinated, yet the football team was

forced to withdraw from the Hawaii Bowl because of COVID and the basketball

team was forced to withdraw from the Diamond Head Classic because of COVID;

the state of Hawaii is 75 percent vaccinated (80 percent of the eligible

population) yet it just went through their worst surge of the entire

pandemic due to omicron.

Check out our own FDA's web site with FAQ about the vaccine:

https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine-frequently-asked-questions

The fourth question is "Who may receive a booster dose of the Pfizer-BioNTech

COVID-19 Vaccine authorized by the FDA?"

Answer: THE FDA updated the EMERGENCY USE AUTHORIZATION for the Pfizer-BioNTech

COVID-19 vaccine to allow for the use of a single booster dose administered at

least 6 months after completion of the vaccine primary series...

I added the emphasis to EMERGENCY USE AUTHORIZATION. The "full approval"

received earlier was for the primary two-dose series. It seems the full

approval does NOT apply to the booster. Those mandating or planning to

mandate the booster appear to be unaware of this, thinking that the vaccine

has full approval for continued used. Also note the AT LEAST 6 MONTHS,

meaning that once you get the booster, you wouldn't be able to get a fourth

shot for at least 6 months, yet the Danish cohort study shows the efficacy

is only 16 percent after the first 30 days, so you're pretty vulnerable for

roughly 5 months.

But also of concern is the answer to the fifth question about the safety

and effectiveness data.

Answer: Safety was evaluated in 306 participants 18 through 55 years of

age and 12 participants 65 years of age and older who were followed for an

average of over two months.

Are you serious? Just 306 participants in one age range, and only TWELVE

in MY age range? Is this a proper clinical study?????

This is not some preprint. This is OUR OWN FDA.

Expand full comment